Herpes is one of the most common viral infections in the world, yet it remains widely misunderstood. Caused by the herpes ...

The trial enrolled and treated 101 immunocompromised patients with refractory or resistant HSV infection.

Investigational antiviral pritelivir demonstrates efficacy and improved tolerability over current treatments for refractory HSV in high-risk patients.

Pritelivir met its primary endpoint of superior lesion healing, achieving a 62.7% lesion healing rate compared to 34.0% with standard-of-care ...

Learn what scientific research and experts say about the evidence for common home remedies for herpes, including honey, lemon balm, and petroleum jelly.

Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global ...

A recent international research project has used advanced microscopy techniques and computational modeling to discover why ...

People have shared their own warnings after a newborn baby was infected with a lethal virus just weeks into her life. Stacey ...

Wuppertal, Germany, January 29, 2026 - Aicuris Anti-infective Cures AG ("Aicuris") today announced that the company will be presenting the results of pritelivir from their pivotal Phase 3 trial (PRIOH ...

SHELTON, CONNECTICUT / ACCESS Newswire / January 13, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a ...

A 58-year-old woman was admitted to the hospital 3 weeks after lumbar surgery because of diplopia and fever. Left leg pain and a rash had preceded the fever and diplopia. A diagnosis was made.